(RTTNews) - NKGen Biotech, Inc. (NKGN) announced the FDA has cleared the company's IND application for SNK01 NK cell therapy for the treatment of Parkinson's disease. SNK01 is an autologous, ...

PDS Biotechnology (NASDAQ:PDSB) said on Thursday it received U.S. FDA clearance for its Investigational New Drug application aimed at evaluating a drug to treat metastatic colorectal carcinoma in ...

PITTSBURGH, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (KRYS) (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company focused on the discovery, development and ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...